Clinical Trial

Post-Marketing Surveillance of Vliwazell® Prowound Dressing

Study acronym: Vliwazell
Recruiting
View on ClinicalTrials.gov →
Summary
This PMCF study is conducted to confirm the effectiveness and safety of the wound dressing Vliwazell® Pro. The aim of the study is to validate the performance of Vliwazell® Pro within its intended purpose and certified indications during routine use, and to gather additional safety data. The study will examine how the use of the dressing affects the condition of the skin surrounding the wound, the wound status in terms of exudate, wound odor, and other parameters. Furthermore, the satisfaction of healthcare providers and patients with the application of the dressing will be assessed.
Trial Details
NCT Number NCT07316556
Lead Sponsor Lohmann & Rauscher
Conditions Acute and Chronic Wounds
Enrollment 208 participants
Start Date 2024-03-11
Primary Completion 2027-01-31 (estimated)
Study Completion 2027-01-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-05